Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors—reference to the effect on intratumor quiescent cells
- 1 June 2000
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 47 (3) , 799-807
- https://doi.org/10.1016/s0360-3016(00)00477-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Therapeutic potential of the anti‐angiogenesis drug TNP‐470International Journal of Experimental Pathology, 1998
- Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsInvestigational New Drugs, 1997
- Influence of an anti‐angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapyInternational Journal of Cancer, 1995
- Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)British Journal of Cancer, 1994
- Antiangiogenic agents can increase tumor oxygenation and response to radiation therapyRadiation Oncology Investigations, 1994
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasisJournal of Pediatric Surgery, 1993
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990